In device-detected AF, DOACs vs. aspirin or placebo reduce ischemic stroke and increase major bleeding - KIVIRID

In device-detected AF, DOACs vs. aspirin or placebo reduce ischemic stroke and increase major bleeding

Authors: Geoffrey D. Barnes

Published: 2024-07-01

DOI: 10.7326/annals-24-00652-jc

Source: Full article

Abstract

No abstract found.